Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Adenosine Triphosphate and Emodin

Research Papers that Mention the Interaction

The pharmacological tests showed that emodin significantly activated PPARα/γ and AMPK, decreased fatty acid biosynthesis, and increased intracellular ATP levels.
BioMed research international  •  2021  |  View Paper
ATP elicited increases in intracellular Ca(2+) concentration were reduced by 35 and 60% by 1 and 10 µM emodin , respectively.
Carcinogenesis  •  2013  |  View Paper
In addition, emodin prevented the depletion of NAD+ and ATP induced by zinc.
Bioscience reports  •  2019  |  View Paper
Furthermore, emodin altered protein abundance of Bcl-2, Bax and claudin-1 and attenuated EMT caused by ATP.
Cellular Physiology and Biochemistry  •  2017  |  View Paper
We found that emodin induced apoptosis and significantly decreased mitochondrial membrane potential and ATP release in these cells.
Cellular Oncology  •  2015  |  View Paper
Aloe-emodin caused a time-dependent decrease in intracellular ATP levels, which might be related to direct inhibition of ATP synthase.
European journal of pharmacology  •  2007  |  View Paper
ATP (… emodin , in a dose-dependent manner with IC50 of 0.5 μM. Furthermore, emodin reduced the IL-1β release induced by ATP (2 mM) in … suppressed the ROS production and phagocytosis attenuation triggered by ATP (1 mM), with IC50 values of 1 μM and 0.7 μM, respectively.
Pharmaceutical biology  •  2014  |  View Paper
EMD treatment at 3 daily doses (0.6 or 1.2 mmol/kg) could enhance myocardial mitochondrial ATP generation capacity and antioxidant components in both male and female rat hearts, but it only significantly protected against I-R injury in female hearts.
Life sciences  •  2005  |  View Paper
Combined with protoplast flow cytometry and fluorescence, it is revealed that emodin might reduce the synthesis of ATP by lowering the mitochondrial membrane potential, leading to the subsequent responses.
Frontiers in Bioengineering and Biotechnology  •  2021  |  View Paper
Enzyme kinetic assays showed that emodin inhibited CKII activity as a competitive inhibitor against ATP with a Ki value of 7.2 microM. Collectively, we suggest that emodin is a selective CKII inhibitor, whose action mechanism is mediated through competitively binding to the ATP binding site.
Planta medica  •  1999  |  View Paper